Novel trends in the treatment of hypertensive patient

A tétel rövid nézete
dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorShittien, Amina Oumar
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2020-02-24T10:36:35Z
dc.date.available2020-02-24T10:36:35Z
dc.date.created2019-04-08
dc.description.abstractSustained blood pressure of more than 140/90 mmHg recorded twice at different intervals or more than 180/160 mmHg once qualifies as High Blood Pressure. The lack of precise symptoms makes it hard to diagnose and also delays the diagnosis, which supports the name “The Silent Killer”. The most significant approach in the management is to make lifestyle modifications including diet and exercise. This has the potential of reducing the systolic blood pressure by approximately 4 to 11 mmHg for hypertensive patients. Standard of health can also be improved by the use of drugs such as ACE inhibitors, ARB’s, Beta Blockers or Diuretics. The combination of these drugs are more advantageous, therefore individual patients would get the regimen depending on their current state of health and also co-morbidities.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent35hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/281198
dc.language.isoenhu_HU
dc.subjectHypertensive patient managementhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleNovel trends in the treatment of hypertensive patienthu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)